| Product Code: ETC7134773 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Estonia`s insulin drugs and devices import market shows promising growth with a CAGR of 8.49% from 2020-2024. In 2024, top exporters to Estonia include Germany, Lithuania, Italy, Slovenia, and Belgium. Despite the increase in shipments, the market remains competitive with a low Herfindahl-Hirschman Index (HHI) concentration. The growth rate for import shipments from 2023-2024 is particularly strong at 9.4%, indicating a continued positive trend in the market for insulin products in Estonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Insulin Drugs & Devices Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Insulin Drugs & Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Estonia Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 Estonia Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 Estonia Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2022 & 2032F |
3.6 Estonia Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2022 & 2032F |
3.7 Estonia Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2022 & 2032F |
3.8 Estonia Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2022 & 2032F |
4 Estonia Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Estonia Insulin Drugs & Devices Market Trends |
6 Estonia Insulin Drugs & Devices Market, By Types |
6.1 Estonia Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2022 - 2032F |
6.1.3 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2022 - 2032F |
6.1.4 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2022 - 2032F |
6.1.5 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2022 - 2032F |
6.1.6 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2022 - 2032F |
6.2 Estonia Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2022 - 2032F |
6.2.3 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2022 - 2032F |
6.3 Estonia Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 Estonia Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2022 - 2032F |
6.3.3 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2022 - 2032F |
6.4 Estonia Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.4.3 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2022 - 2032F |
6.4.4 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2022 - 2032F |
6.4.5 Estonia Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2022 - 2032F |
7 Estonia Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 Estonia Insulin Drugs & Devices Market Export to Major Countries |
7.2 Estonia Insulin Drugs & Devices Market Imports from Major Countries |
8 Estonia Insulin Drugs & Devices Market Key Performance Indicators |
9 Estonia Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 Estonia Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2022 & 2032F |
9.2 Estonia Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2022 & 2032F |
9.3 Estonia Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2022 & 2032F |
9.4 Estonia Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2022 & 2032F |
10 Estonia Insulin Drugs & Devices Market - Competitive Landscape |
10.1 Estonia Insulin Drugs & Devices Market Revenue Share, By Companies, 2025 |
10.2 Estonia Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here